Travere Therapeutics, Inc.

TVTX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$49.30-2.15%

2026-11-02

Financials

Valuation Metrics

Travere Therapeutics, Inc.'s Market Cap is $4.59B. At end of 2025 it was $3.45B. Ranked #1354 of 3,116 in US market (top 43%), #464 of 1,470 on NASDAQ (top 32%), #79 of 265 in Pharmaceuticals, Biotechnology & Life Sciences (top 30%) by Market Cap.

Investment Metrics(as of 2026-11-02)

Metric	Value	Rank
Size
Market Cap	$4.59B	US#1,354/3,116 Sec#79/265
Revenue	$591M	US#2,167/3,116 Sec#73/265
Net Income	$-43M	US—/3,116 Sec—/265
Total Assets	$799M	US#2,566/3,116 Sec#118/265
Net Assets	$25M	US#2,884/3,116 Sec#232/265
Value
P/B	186.98x	US#2,909/3,116 Sec#239/265
P/S	7.75x	US#2,624/3,116 Sec#106/265
EV/EBITDA	3292.87x	US#2,510/3,116 Sec#87/265
FCF Yield	1.12%	US#2,167/3,116 Sec#77/265
Profitability
ROE	-177.24%	US#2,833/3,116 Sec#216/265
ROA	-5.44%	US#2,539/3,116 Sec#91/265
Op. Margin	-6.84%	US#2,481/3,116 Sec#88/265
Revenue Growth	77.12%	US#136/3,116 Sec#37/265
Financial Health
Debt Ratio	3159.77%	US#2,882/3,116 Sec#237/265
Total Debt	$617M	US#1,767/3,116 Sec#59/265
FCF	$52M	US#1,973/3,116 Sec#71/265
Cash	$118M	US#2,114/3,116 Sec#162/265
Current Ratio	4.05x	US#571/3,116 Sec#163/265
Performance
1Y Return	40.23%	US#193/3,116 Sec#37/265
1M Return	-13.39%	US#2,728/3,116 Sec#200/265
From 52W High	-28.26%	US#1,654/3,116 Sec#98/265
1Y MDD	-33.49%	US#1,553/3,116 Sec#79/265
Trading
Volume	2,314,554 shares	US#954/3,116 Sec#101/265
Trading Value	$116M	US#886/3,116 Sec#63/265
Per Share
EPS	$-0.47	US—/3,116 Sec—/265
BPS	$0.26	US#2,779/3,116 Sec#225/265